Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0002 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0003 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.2 | 0.0004 |